BriaCell Therapeutics (BCTXL) Stock: Why It Moved Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $0.90 as of 12:05 PM ET, +0.22% vs the prior close of $0.90.
- Volume 6.14K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BCTXL is flat (+0.2%) to $0.90. Trading at $0.90 (intraday, 12:05 PM ET), +0.22% vs the prior close of $0.90. Day range $0.86–$0.94, opened at $1.00.
BCTXL daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BCTXL is flat (+0.2%) to $0.90
- Trading at $0.90 (intraday, 12:05 PM ET), +0.22% vs the prior close of $0.90. Day range $0.86–$0.94, opened at $1.00.
- Volume was 6.14K shares, 0.1x its 50-day average of 53.55K — lighter than usual.
- 52-week range $0.86–$0.95; the current price sits at 44% of that range, 5.3% below the 52-week high.
BCTXL bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Latest fiscal-year net income: loss of $26.31M.
- Share count up 28.4% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BCTXL latest news & SEC filings
Every SEC filing by or about BCTXL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade BCTXL
- Last results release: Oct 28, 2022 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 0.22% (largest 0.2%). That is a relatively calm stock.
- Liquidity: about 29.85K shares (≈$26.86K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.90 vs a range of $0.86–$0.95 (44% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Jun 26, 2026; 10-Q Jun 9, 2026; 8-K Jun 3, 2026.
- Share count: 8.70M shares outstanding (Jun 9, 2026), +28.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BCTXL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.00 | 0.94 | 0.86 | 0.90 | 6.14K |
| Oct 16, 2026 | 1.00 | 0.95 | 0.87 | 0.90 | 53.55K |
About BriaCell Therapeutics
BriaCell Therapeutics (BCTXL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WEST VANCOUVER, British Columbia, Canada. State of incorporation: British Columbia, Canada. Fiscal year ends July 31. SEC CIK 1610820.
BCTXL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BCTXL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jul 31, 2025 | — | $-26.31M | -62.19 | $-28.17M |
| Jul 31, 2024 | — | $-4.79M | -43.68 | $-24.13M |
| Jul 31, 2023 | — | $-20.30M | -1.30 | $-23.74M |
| Jul 31, 2022 | — | $-26.84M | -1.73 | $-12.48M |
| Jul 31, 2021 | — | $-13.82M | — | $-7.75M |
Latest balance sheet: total assets $27.07M, total liabilities $—, cash $6.88M (as of Apr 30, 2026).
BCTXL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 28, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BCTXL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.